Uterine Fibroids and Fertility: Which Fibroids Matter Most
Key Takeaways
Many women with fibroids can become pregnant. Fibroids that change the shape of the uterine cavity deserve particular attention; for those that do not, the fertility benefit of surgery remains uncertain. The decision also depends on symptoms, age, ovarian reserve and the time needed for recovery.
Key evidence: ASRM: when myomectomy may improve pregnancy rates (2017) Cochrane: uncertainty about fertility benefits of surgery (2020) Intramural fibroid surgery before IVF: systematic review (2026)
Uterine fibroids are benign growths in the muscle of the womb. They are common and may be found during a scan even when you have no symptoms (NHS patient information).
Finding one can raise an immediate question: Will this stop me getting pregnant, and does it need to be removed? The scan needs to show more than its diameter. Its position, your symptoms and the rest of your fertility assessment help determine what to do next.
What are uterine fibroids, and how are they classified?
The FIGO classification describes where a fibroid lies in relation to the uterine lining, muscle and outer surface. It is an anatomical description, not a surgery score (FIGO classification guidance, 2025).
- Types 0–2: submucosal fibroids. They project into the cavity; the types differ in how much lies within the muscle.
- Type 3: entirely within the muscle, but touching the lining without distorting the cavity. Type 4: surrounded by muscle, without touching the lining or outer surface.
- Types 5–7: subserosal fibroids. They grow towards the outside. Type 5 has a substantial intramural part; type 7 is attached by a stalk.
- Type 8 and hybrid types: other sites, such as the cervix, or fibroids involving both inner and outer surfaces.
Contact with the lining and distortion of the cavity are different findings. Ask which is present in your scan report.
Who needs a closer assessment?
A fibroid deserves review when you are preparing for IVF, have difficulty conceiving, have had repeated pregnancy losses, or have troublesome bleeding, pain or pressure. It should not automatically be assumed to explain infertility.
Ultrasound is usually the first investigation. If the cavity is unclear, saline ultrasound or hysteroscopy may help; MRI can clarify complex anatomy before treatment. Not everyone needs every test (guidance on fibroid imaging).
Bring the images as well as the report, and explain how your symptoms affect daily life. If bleeding is heavy, ask whether you need a blood test for anaemia. Other findings, including uterine polyps or adenomyosis, may need a separate assessment.
How do fibroids affect fertility?
Fibroids projecting into the cavity are of particular concern because they can interfere with implantation. Changes in uterine contractions and the lining have also been proposed as mechanisms, but they cannot predict an individual patient’s outcome (FIGO review of fibroids and infertility, 2026).
An association with fewer pregnancies does not, by itself, prove that removing the fibroid will help. This distinction matters most for intramural fibroids that leave the cavity’s shape unchanged.
What does the evidence support, and what remains uncertain?
The benefit of surgery depends on the finding and on the outcome being measured. A pregnancy seen on ultrasound is not the same outcome as a live birth.
| Finding | What to discuss before treatment |
|---|---|
| Fibroid projecting into or distorting the cavity | Removal may improve pregnancy rates. Hysteroscopic removal has better support for clinical pregnancy than for live birth or miscarriage prevention. |
| Intramural fibroid without cavity distortion | Some studies find poorer fertility outcomes, but the benefit of removal remains unsettled. There is no universal size threshold for surgery. |
| Subserosal fibroid | Removal solely to improve fertility is not supported; symptoms or access to the ovaries may still matter. |
These distinctions follow ASRM’s guidance. The 2020 Cochrane review found very limited randomized evidence, so surgery cannot be presented as reliably restoring fertility.
Recent intramural-fibroid reviews differ. A 2024 meta-analysis did not demonstrate a clear improvement in clinical pregnancy after removal. That does not prove that surgery has no benefit.
A 2026 review of seven non-randomized studies reported better ongoing-pregnancy/live-birth outcomes after surgery before IVF/ICSI, but fibroid definitions and outcome reporting varied. Selection differences may affect the comparison. Neither result establishes a rule for every patient.
Which treatment options may be considered?
Treatment can address symptoms, a fertility concern, or both. Make sure the reason for any proposed procedure is clear.
Hysteroscopic myomectomy
A small instrument passes through the cervix to remove a fibroid projecting into the cavity. Suitability depends on its depth and size; some procedures need more than one stage. Bleeding, perforation and adhesions inside the uterus are possible complications (FIGO treatment discussion).
Laparoscopic or open myomectomy
Fibroids within the wall or on the outside may require abdominal surgery. The route depends on their number, position, depth, the repair needed and the surgical team’s experience. A diameter alone does not decide whether open surgery is necessary. See the limits of laparoscopic myomectomy.
Both routes can involve bleeding, adhesions and a uterine scar. Available trials do not establish one route as better for live birth (Cochrane review).
Observation
Monitoring can be reasonable when symptoms are manageable and there is no clear reason to operate. Agree on what would prompt reassessment, such as changing symptoms or imaging findings. Treatments that control bleeding also need to fit your pregnancy plans (NHS treatment overview).
How should surgery and IVF be timed?
The interval before pregnancy or embryo transfer should be set with your surgeon and fertility team. It depends on the procedure, uterine repair and recovery. A systematic review on timing after myomectomy found insufficient evidence to recommend one minimum wait. It covered open, laparoscopic, robotic and vaginal myomectomy, but not hysteroscopic removal. Its findings cannot set the timetable for every type of procedure.
Egg retrieval and embryo transfer can be planned separately. Whether retrieval before surgery is suitable depends on safe access to the ovaries and the reason surgery is needed.
If travelling for care, obtain an individual plan for follow-up and return travel before booking. An uncomplicated hysteroscopy and surgery involving deep uterine repair require different arrangements.
Dr. Aksoy’s approach
Dr. Aksoy does not routinely recommend surgery for an intramural fibroid that does not distort the cavity. Findings that change his assessment include:
- Rapid growth or a suspicious appearance on imaging;
- Significant bleeding, pain or pressure;
- Difficulty reaching the follicles during egg retrieval;
- 3D ultrasound or MRI showing that the cavity is actually distorted.
In a patient with low ovarian reserve or older reproductive age, he considers egg retrieval and embryo freezing first when surgery is necessary but would postpone transfer for several months. Transfer is then planned after uterine recovery. This is his clinical approach to sequencing care, not a guarantee of obtaining embryos or achieving pregnancy.
Rapid growth calls for reassessment; it does not by itself diagnose cancer. If imaging is suspicious, the investigation of that finding takes priority over a routine fertility schedule (FIGO diagnostic guidance).
When should you seek medical help?
Seek urgent medical care for sudden severe pelvic pain or very heavy vaginal bleeding. Do not wait for faintness or breathlessness to develop (Mayo Clinic: when to seek care).
Being suddenly unable to pass urine also needs immediate medical attention (NIDDK: acute urinary retention). Do not assume that a known fibroid explains a new severe symptom without examination.
Arrange a review for persistent heavy periods, worsening pressure or a new change in symptoms. Fibroids can cause anaemia and bladder or bowel symptoms (NHS information on symptoms and complications).
Questions to bring to your consultation
- Does the fibroid touch the lining, distort the cavity, or neither?
- What is the goal of surgery in my case, and how certain is the expected benefit?
- What are the risks of operating and of monitoring it?
- If surgery is needed, could egg retrieval come first, and what would make that unsuitable?
- How will recovery be assessed before pregnancy or embryo transfer?
FAQ
Does a 4 cm fibroid always need removal?
No. Size alone does not establish a fertility indication for surgery. Its relationship to the cavity, symptoms and the broader treatment plan matter (ASRM guidance).
Can a fibroid touching the lining matter without distorting it?
Yes. A FIGO type 3 fibroid touches the lining without projecting into the cavity (FIGO classification). This finding should be considered during your fertility assessment, but contact alone does not establish that removal will help. Evidence supporting surgery for fibroids that distort the cavity cannot simply be applied to type 3 fibroids (ASRM guidance).
Does waiting three to six months after surgery make pregnancy safe?
No fixed interval guarantees a risk-free pregnancy. The timing review could not establish a minimum wait after the forms of myomectomy it studied, which did not include hysteroscopic removal. Follow the recommendation based on your operation and recovery; this uncertainty is not a reason to shorten the advised wait yourself.
Does little effect on implantation mean no risk during pregnancy?
No. Implantation and pregnancy complications are different questions. The size and position of remaining fibroids, and any previous uterine surgery, still inform pregnancy follow-up (FIGO fertility review).
Sources
- Practice Committee of the American Society for Reproductive Medicine. Removal of myomas in asymptomatic patients to improve fertility and/or reduce miscarriage rate: a guideline. Fertil Steril. 2017;108(3):416–425. doi:10.1016/j.fertnstert.2017.06.034.
- Lakabi R, Harth S, Meinhold-Heerlein I, Olsthoorn AV, Munro MG, Murji A. Diagnosis and classification of uterine fibroids. Int J Gynaecol Obstet. 2025;171(2):566–573. doi:10.1002/ijgo.70538.
- Metwally M, Raybould G, Cheong YC, Horne AW. Surgical treatment of fibroids for subfertility. Cochrane Database Syst Rev. 2020;1:CD003857. doi:10.1002/14651858.CD003857.pub4.
- Pritts TL, Ogden M, Parker W, Ratcliffe J, Pritts EA. Intramural Leiomyomas and Fertility: A Systematic Review and Meta-Analysis. Obstet Gynecol. 2024;144(2):171–179. doi:10.1097/AOG.0000000000005661.
- Verma S, Shanbhag A, Salim S, Potdar N. Myomectomy for intramural fibroids prior to in vitro fertilization/intracytoplasmic sperm injection cycles, a conundrum: Systematic review and meta-analysis. Int J Gynaecol Obstet. 2026;173(3):1256–1264. Published online 18 December 2025. doi:10.1002/ijgo.70748.
- Margueritte F, Adam C, Fauconnier A, Gauthier T. Time to conceive after myomectomy: should we advise a minimum time interval? A systematic review. Reprod Biomed Online. 2021;43(3):543–552. doi:10.1016/j.rbmo.2021.05.016.
- Mocanu E, Tarlatzis B, Feldberg D, Diaz I, O’Brien C, Purandare N. Fibroids and infertility. Int J Gynaecol Obstet. 2026;174(1):11–16. doi:10.1002/ijgo.71062.
- NHS. Fibroids. Patient information, reviewed 17 March 2026; accessed 16 September 2026.
- Mayo Clinic. Uterine fibroids: symptoms and causes. Patient information; accessed 16 September 2026.
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Symptoms & Causes of Urinary Retention. Patient information; accessed 16 September 2026.
Add as a Preferred Source on Google
You can add draksoyivf.com as one of your preferred health information sources on Google.
The content has been created by Dr. Senai Aksoy and medically approved.